Dare Bioscience (DARE) Assets Average (2014 - 2026)

Dare Bioscience (DARE) has reported Assets Average for 13 consecutive years, with $27.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 73.57% year-over-year to $27.4 million; the trailing twelve-month figure through Jun 2026 stood at $27.4 million (up 73.57% YoY), and the FY2025 full-year result was $27.3 million, up 25.8% from the prior year.
• Assets Average fell to $27.4 million in Q2 2026 per DARE's latest filing, from $31.6 million in the prior quarter.
• Across five years, Assets Average topped out at $52.5 million in Q1 2022 and bottomed at $15.8 million in Q2 2025.
• Historically, Assets Average has averaged $29.7 million across 5 years, with a median of $24.1 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Assets Average surged 481.07% in 2022, then slumped 53.78% in 2024.
• Over 5 years, Assets Average stood at $47.1 million in 2022, then slumped by 50.81% to $23.2 million in 2023, then retreated by 13.33% to $20.1 million in 2024, then soared by 57.43% to $31.6 million in 2025, then decreased by 13.25% to $27.4 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $27.4 million, $31.6 million, and $21.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.